MedPath

优尼特尔南京制药有限公司

Ownership
-
Established
2004-01-05
Employees
-
Market Cap
-
Website
https://www.unither-pharma.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

Tobramycin Eye Drops

Product Name
妥布霉素滴眼液
Approval Number
国药准字H20183153
Approval Date
Apr 18, 2024
NMPA

Ofloxacin Eye Drops

Product Name
氧氟沙星滴眼液
Approval Number
国药准字H20083296
Approval Date
Mar 13, 2023
NMPA

Polyvinyl Alcohol Eye Drops

Product Name
聚乙烯醇滴眼液
Approval Number
国药准字H20183006
Approval Date
Dec 8, 2022
NMPA

Ketorolac Tromethamine Eye Drops

Product Name
酮咯酸氨丁三醇滴眼液
Approval Number
国药准字H20173404
Approval Date
Nov 21, 2022
NMPA

Topotecan Hydrochloride Capsules

Product Name
欣泽
Approval Number
国药准字H20070204
Approval Date
May 6, 2022
NMPA

Topotecan Hydrochloride Capsules

Product Name
欣泽
Approval Number
国药准字H20070203
Approval Date
May 6, 2022
NMPA

Spironolactone Tablets

Product Name
螺内酯片
Approval Number
国药准字H20163054
Approval Date
Dec 25, 2020
NMPA

Licorzine Granules

Product Name
甘草锌颗粒
Approval Number
国药准字H20153318
Approval Date
Nov 26, 2020
NMPA

Licorzine Granules

Product Name
甘草锌颗粒
Approval Number
国药准字H20153317
Approval Date
Nov 26, 2020
NMPA

Proparacaine Hydrochloride

Product Name
盐酸丙美卡因
Approval Number
国药准字H20100098
Approval Date
Jun 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy